NO20043634L - Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister - Google Patents

Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister

Info

Publication number
NO20043634L
NO20043634L NO20043634A NO20043634A NO20043634L NO 20043634 L NO20043634 L NO 20043634L NO 20043634 A NO20043634 A NO 20043634A NO 20043634 A NO20043634 A NO 20043634A NO 20043634 L NO20043634 L NO 20043634L
Authority
NO
Norway
Prior art keywords
ester
mono
dopamine
asymmetrically substituted
receptor agonists
Prior art date
Application number
NO20043634A
Other languages
English (en)
Norwegian (no)
Inventor
Durk Dijkstra
Hakan Wikstrom
Original Assignee
Darpharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200478A external-priority patent/SE0200478D0/xx
Priority claimed from SE0200474A external-priority patent/SE0200474D0/xx
Application filed by Darpharma Inc filed Critical Darpharma Inc
Publication of NO20043634L publication Critical patent/NO20043634L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043634A 2002-02-15 2004-08-31 Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister NO20043634L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200478A SE0200478D0 (sv) 2002-02-15 2002-02-15 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine D1 receptor agonist A-86929
SE0200474A SE0200474D0 (sv) 2002-02-17 2002-02-17 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine D1 receptor agonists Dihydrexidine and Dinapsoline
PCT/US2003/004592 WO2003070245A1 (en) 2002-02-15 2003-02-14 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists

Publications (1)

Publication Number Publication Date
NO20043634L true NO20043634L (no) 2004-11-11

Family

ID=27759833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043634A NO20043634L (no) 2002-02-15 2004-08-31 Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister

Country Status (11)

Country Link
US (1) US7220754B2 (da)
EP (1) EP1480647B1 (da)
JP (1) JP2005526728A (da)
AT (1) ATE406896T1 (da)
AU (1) AU2003217430B2 (da)
CA (1) CA2476115A1 (da)
DE (1) DE60323339D1 (da)
DK (1) DK1480647T3 (da)
ES (1) ES2314189T3 (da)
NO (1) NO20043634L (da)
WO (1) WO2003070245A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9046537B2 (en) 2003-09-22 2015-06-02 Enzo Biochem, Inc. Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
AU2004308413A1 (en) * 2003-12-23 2005-07-14 Darpharma, Inc. Co-administration of dopamine-receptor binding compounds
US9052324B2 (en) 2004-05-19 2015-06-09 Enzo Biochem, Inc. Compounds and assays for controlling Wnt activity
US8596306B2 (en) * 2005-10-27 2013-12-03 Synthetic Gas Solutions, Llc Perfluorocarbon gas insufflation
CA2643300C (en) * 2006-02-21 2011-11-08 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
WO2010124005A1 (en) 2009-04-21 2010-10-28 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
AU2013343104A1 (en) * 2012-11-08 2015-04-23 Pfizer Inc. Heteroaromatic compounds and their use as dopamine D1 ligands

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340600A (en) * 1980-05-22 1982-07-20 Smithkline Corporation Renal dilating methods and compositions using 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines
US4282227A (en) * 1980-05-22 1981-08-04 Smithkline Corporation Renal vasodilating 3,4-dihydroxyphenyltetrahydrothienopyridines
JPH02138A (ja) * 1987-09-18 1990-01-05 Banyu Pharmaceut Co Ltd L‐ドーパ誘導体
US5047536A (en) * 1989-03-17 1991-09-10 Purdue Research Foundation Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) * 1990-09-07 1992-03-11 Abbott Lab Phenanthridine compounds
KR100292928B1 (ko) * 1992-05-26 2001-11-05 프란시스 제이 메이어 치환된헥사하이드로벤조페난트리딘
BR9405972A (pt) * 1993-04-06 1995-12-12 Abbott Lab Composto composição farmaceutica e processo para tratar distúrbios neurológicos psicológicos cardiovasculares cognitivos ou de falta de atenção ou de comportamento que levam ao vicio ou uso de substancias ou uma combinação destas indicações
CA2195239A1 (en) * 1994-07-15 1996-02-01 David E. Nichols Optically active isomers of dihydrexidine and its substituted analogs
BR9610323A (pt) * 1995-08-18 1999-12-21 Perdue Research Foundation Novas isoquinolinas fundidas como ligantes de receptor de dopamina

Also Published As

Publication number Publication date
WO2003070245B1 (en) 2004-05-27
CA2476115A1 (en) 2003-08-28
EP1480647A1 (en) 2004-12-01
WO2003070245A1 (en) 2003-08-28
ATE406896T1 (de) 2008-09-15
DK1480647T3 (da) 2009-01-26
AU2003217430B2 (en) 2008-10-23
DE60323339D1 (de) 2008-10-16
EP1480647B1 (en) 2008-09-03
ES2314189T3 (es) 2009-03-16
US20050096469A1 (en) 2005-05-05
EP1480647A4 (en) 2005-07-13
US7220754B2 (en) 2007-05-22
JP2005526728A (ja) 2005-09-08
AU2003217430A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
CY1112941T1 (el) Δικυκλικοι αναστολεις της μεκ
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
CR9587A (es) Derivados de piridazina
HRP20050191B1 (hr) Novi derivati benzoimidazola korisni kao antiproliferativna sredstva
NO20062098L (no) Faststofftilstandmontelukast
MX2007004699A (es) Derivados de indol y bencimidazol.
BR9904162A (pt) 4-carboxiamino-2-metil-1,2,3,4-tetra-hidroquinolinas aneladas
SE0201635D0 (sv) Novel compounds
IL204594A (en) Protein kinase inhibitors
BRPI0506477A (pt) compostos farmaceuticamente úteis e inovadores
ATE556058T1 (de) 1-(2h)-isochinolonderivat
CA2757418C (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
GEP20084572B (en) Novel quinoline derivatives
ECSP088229A (es) Derivados de pirazolona como inhibidores de 11-beta hsd1
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
IN266803B (da)
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
NO20043634L (no) Mono-ester- og asymmetrisk substituerede di-ester-prodrugs av dopamin D1 reseptoragonister
AR004512A1 (es) Derivados de benzotiazolona, procedimientos para su preparacion, compuestos intermediarios utiles para llevar a cabo dicho procedimiento ycomposiciones farmaceuticas que comprenden dichos derivados
DE60002733D1 (de) Diester prodrugs von decahydroischinoline-3-carbonsäure
DE60222131D1 (de) Neues alkaloidderivat und dieses enthaltende pharmazeutische zusammensetzung
WO2004091627A3 (en) Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs